The Blog
-
Nov 27, 2024Targeting DNA Damage Checkpoint Kinases: A New Frontier in Precision Cancer Therapy
READ MORE -
Nov 25, 2024Aurora Kinase B: Unlocking New Horizons in Cancer Therapy
READ MORE -
Nov 19, 2024Enhancing Topoisomerase I Inhibitor-Based Antibody-Drug Conjugates: Strategies and Future Directions in Cancer Therapy
READ MORE -
Nov 12, 2024Advancing Cancer Therapy with Catalytic Topoisomerase II Inhibitors: A Safer Pathway Forward
READ MORE -
Oct 30, 2024The Role of Cyclin-Dependent Kinases (CDKs) in Cancer: Biomarkers, Therapeutic Targets, and Future Directions
READ MORE -
Aug 12, 2024Exploring the Versatility of Heparin: From Anticoagulant to Multifaceted Therapeutic Agent
READ MORE -
Jul 08, 2024Nintedanib: A Multifaceted Tyrosine Kinase Inhibitor
READ MORE -
Jun 07, 2024Exploring the Role of Toll-like Receptor (TLR) Agonists in Cancer Therapy
READ MORE -
Apr 06, 2023Dopamine Receptor and Cancer
READ MORE